PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wuling Motors Holdings Limited (0305.HK)
0.690.03 (-4.17%)
0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
69.45%
Revenue growth 1.25-1.5x 0425.HK's 57.09%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
283.79%
Gross profit growth above 1.5x 0425.HK's 102.21%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
229.63%
EBIT growth 1.25-1.5x 0425.HK's 182.35%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
229.63%
Operating income growth 1.25-1.5x 0425.HK's 182.35%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
183.19%
Net income growth comparable to 0425.HK's 177.36%. Walter Schloss might see both following similar market or cost trajectories.
171.60%
EPS growth similar to 0425.HK's 178.13%. Walter Schloss would assume both have parallel share structures and profit trends.
171.60%
Similar diluted EPS growth to 0425.HK's 178.13%. Walter Schloss might see standard sector or cyclical influences on both firms.
16.23%
Slight or no buybacks while 0425.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
16.16%
Slight or no buyback while 0425.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-5.02%
Negative OCF growth while 0425.HK is at 166.34%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-3.95%
Negative FCF growth while 0425.HK is at 164.71%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-25.20%
Negative 10Y revenue/share CAGR while 0425.HK stands at 268.15%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-14.92%
Negative 5Y CAGR while 0425.HK stands at 74.17%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
78.46%
3Y revenue/share CAGR above 1.5x 0425.HK's 24.70%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-879.87%
Negative 10Y OCF/share CAGR while 0425.HK stands at 272.13%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-38.06%
Negative 5Y OCF/share CAGR while 0425.HK is at 95.31%. Joel Greenblatt would question the firm’s operational model or cost structure.
-2020.15%
Negative 3Y OCF/share CAGR while 0425.HK stands at 35.90%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
618.94%
Net income/share CAGR above 1.5x 0425.HK's 133.15% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
82.63%
5Y net income/share CAGR above 1.5x 0425.HK's 52.44%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
135.49%
3Y net income/share CAGR above 1.5x 0425.HK's 5.70%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
109.13%
10Y equity/share CAGR at 50-75% of 0425.HK's 154.38%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
-16.14%
Negative 5Y equity/share growth while 0425.HK is at 56.93%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
41.33%
3Y equity/share CAGR above 1.5x 0425.HK's 23.57%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-91.69%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.95%
AR growth is negative/stable vs. 0425.HK's 28.07%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-33.37%
Inventory is declining while 0425.HK stands at 14.53%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-10.25%
Negative asset growth while 0425.HK invests at 11.34%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.50%
We have a declining book value while 0425.HK shows 6.43%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-55.61%
We’re deleveraging while 0425.HK stands at 5.55%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.41%
Our R&D shrinks while 0425.HK invests at 104.02%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
71.83%
SG&A growth well above 0425.HK's 50.27%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.